Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;18(2):56-62.
doi: 10.14740/gr2029. Epub 2025 Apr 20.

Procalcitonin as a Predictor of Mortality in Patients With Severe Acute Pancreatitis

Luis Ricardo Ramirez-Gonzalez  1 , Leonardo Rafael Ordonez-Forestiery  1 , Andrea Garcia  2 , Maximiliano Cesar Iniguez-Martin-Del-Campo  2 , Francia Damary Llamas-Hernandez  2 , Kathia Dayana Morfin-Meza  2 , Samantha Emily Gonzalez-Munoz  2 , Carlos Enrique Capetillo-Texson  2 , Jose Pablo Gomez-Sierra  2 , Luis Osvaldo Suarez-Carreon  1   3 , Gabino Cervantes-Guevara  4 , Enrique Cervantes-Perez  5 , Sol Ramirez-Ochoa  5 , Andrea Socorro Alvarez-Villasenor  6 , Ana Olivia Cortes-Flores  7 , Alejandro Gonzalez-Ojeda  8 , Clotilde Fuentes-Orozco  2
Affiliations

Procalcitonin as a Predictor of Mortality in Patients With Severe Acute Pancreatitis

Luis Ricardo Ramirez-Gonzalez et al. Gastroenterology Res. 2025 Apr.

Abstract

Background: Acute pancreatitis (AP) is a severe inflammatory disorder that begins with the inappropriate activation of pancreatic enzymes within acinar cells due to biliary reflux, alcohol abuse, gallstones, and autoimmune disease. Several biomarkers have been studied that may aid in the early detection of pancreatic necrosis. The aim of this project was to evaluate the usefulness of procalcitonin (PCT) in predicting mortality in patients with severe AP in Mexican population.

Methods: An observational study, including 59 patients diagnosed with AP from 2018 to 2023, was conducted in a tertiary care hospital. Serum PCT levels were assessed on the first and third days of hospitalization (24 and 72 h).

Results: A total of 59 patients were included, and the main etiologies were lithiasis (28 patients, 47.5%) and endoscopic retrograde cholangiopancreatography (ERCP) (nine patients, 15.3%). Of the total patients, 16 (27.1%) died during their hospital stay, and the main etiologies were septic shock of abdominal origin (10 patients, 62.5%) followed by extra-abdominal shock (six patients, 37.5%). The average PCT level was 4.54 ± 8.12 on the first day of hospital stay, and 5.20 ± 10.90 at 72 h. The cut-off point was 1.26 ng/mL with the best sensitivity and specificity of PCT as a predictor of mortality at 72 h of 75% and 68%, respectively (area under the curve 0.7, 95% confidence interval (CI): 0.61 - 0.88), and positive and negative predictive values of 0.46 and 0.87, respectively.

Conclusions: We propose the usefulness of PCT as a biochemical marker to predict mortality in patients with severe AP due to its accessibility in the hospital environment. We propose to carry out studies with more patients and follow-up times. In addition, it is necessary to consider other biomarkers associated with PCT to help us improve the positive predictive value of mortality in this disease.

Keywords: Mortality; Procalcitonin; Severe acute pancreatitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
PCT and scales of ROC curve. PCT: procalcitonin; ROC: receiver operating characteristic.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Severino A, Varca S, Airola C, Mezza T, Gasbarrini A, Franceschi F, Candelli M. et al. Antibiotic utilization in acute pancreatitis: a narrative review. Antibiotics (Basel) 2023;12(7):1120. doi: 10.3390/antibiotics12071120. - DOI - PMC - PubMed
    1. Jia Z, Xu J, Gu Y, Zheng L, Xia T. Values of different biochemical indices and clinical scoring systems for the assessment of acute biliary pancreatitis in a Chinese population. Am J Transl Res. 2023;15(5):3300–3308. - PMC - PubMed
    1. Li W, Ou L, Fu Y, Chen Y, Yin Q, Song H. Risk factors for concomitant infectious pancreatic necrosis in patients with severe acute pancreatitis: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2022;46(5):101901. doi: 10.1016/j.clinre.2022.101901. - DOI - PubMed
    1. Andrade-Davila VF, Chavez-Tostado M, Davalos-Cobian C, Garcia-Correa J, Montano-Loza A, Fuentes-Orozco C, Macias-Amezcua MD. et al. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial. BMC Gastroenterol. 2015;15:85. doi: 10.1186/s12876-015-0314-2. - DOI - PMC - PubMed
    1. Fuentes-Orozco C, Davalos-Cobian C, Garcia-Correa J, Ambriz-Gonzalez G, Macias-Amezcua MD, Garcia-Renteria J, Rendon-Felix J. et al. Antioxidant drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: what does evidence suggest? World J Gastroenterol. 2015;21(21):6745–6753. doi: 10.3748/wjg.v21.i21.6745. - DOI - PMC - PubMed

LinkOut - more resources